Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-024811
Filing Date
2019-10-02
Accepted
2019-10-02 21:24:43
Documents
2
Period of Report
2019-10-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1549
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4877
  Complete submission text file 0000899243-19-024811.txt   7760
Mailing Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878 240-780-6356
Viela Bio, Inc. (Issuer) CIK: 0001734517 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560
Business Address
Nolet Chris (Reporting) CIK: 0001782814 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39067 | Film No.: 191134149